Tesamorelin: Your Guide to Growth Hormone Peptide Therapy Benefits
Tesamorelin: Growth Hormone Releasing Peptide Therapy What is the Peptide Tesamorelin? Tesamorelin, an FDA-approved synthetic peptide , acts as a growth hormone-releasing hormone (GHRH), stimulating the pituitary gland to release growth hormone. This triggers the breakdown of lipids and triglycerides, primarily targeting excess fat in the abdomen. It is commonly prescribed to adults with HIV-related lipodystrophy to alleviate abdominal fat accumulation Tesamorelin is particularly effective in targeting visceral fat around the abdomen, leading to a substantial reduction in abdominal weight, typically ranging from fifteen to seventeen percent (15-20%) over a twenty-six-week period. Moreover, recent studies conducted in 2014 have demonstrated its ability to decrease fat accumulation around the liver by as much as eighteen percent (18%). Notably, Tesamorelin has shown promising results in reducing visceral fat buildup in individuals experiencing lipodystrophy linked to HIV infect...